Conflicts of interest and authorship of industry-sponsored publications

British Journal of Dermatology

Volumn 176, Issue 1, 2017, Pages 200-203

  Paul, C ^a   Tauber, M ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; NEW DRUG;

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); CONFLICT OF INTEREST; DRUG INDUSTRY; DRUG MARKETING; HUMAN; MOTIVATION; MULTICENTER STUDY (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHYSICIAN; PRIORITY JOURNAL; PROFESSIONALISM; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); WRITING; ETHICS; EXPERIMENTAL THERAPY; FINANCIAL MANAGEMENT; INTERPERSONAL COMMUNICATION; PUBLIC RELATIONS;

AUTHORSHIP; CLINICAL TRIALS AS TOPIC; CONFLICT OF INTEREST; DISCLOSURE; DRUG INDUSTRY; DRUGS, INVESTIGATIONAL; HUMANS; INTERPROFESSIONAL RELATIONS; RESEARCH SUPPORT AS TOPIC; THERAPIES, INVESTIGATIONAL;

EID: 85010303970     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.15147     Document Type: Article

References (17)

1. Malina D, Rosenbaum L. Reconnecting the dots–reinterpreting industry–physician relations. N Engl J Med 2015; 372:1860–4.
2. Rosenbaum L. Understanding bias–the case for careful study. N Engl J Med 2015; 372:1959–63.
3. Rosenbaum L. Beyond moral outrage–weighing the trade-offs of COI regulation. N Engl J Med 2015; 372:2064–8.
4. Davidoff F, DeAngelis CD, Drazen JM et al. Sponsorship, authorship, and accountability. Arch Otolaryngol Head Neck Surg 2001; 127:1178–80.
5. Williams HC, Naldi L, Paul C et al. Conflicts of interest in dermatology. Acta Derm Venereol 2006; 86:485–97.
6. Anstey A. Conflicts and heuristics in dermatology: time to ask ourselves, ‘What might I do in this situation?’. Br J Dermatol 2015; 173:631–2.
7. Clark J, Gonzalez J, Mansi B et al. Enhancing transparency and efficiency in reporting industry-sponsored clinical research: report from the Medical Publishing Insights and Practices initiative. Int J Clin Pract 2010; 64:1028–33.
8. Marusic A, Hren D, Mansi B et al. Five-step authorship framework to improve transparency in disclosing contributors to industry-sponsored clinical trial publications. BMC Med 2014; 12:197.
9. Graf C, Battisti WP, Bridges D et al. Good publication practice for communicating company sponsored medical research: the GPP2 guidelines. BMJ 2009; 339:b4330.
10. International Committee of Medical Journal Editors. Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals. Available at: http://www.icmje.org/recommendations (last accessed 29 September 2016).
11. PR Newswire. Amgen to terminate participation in co-development and commercialization of brodalumab. Available at: http://www.prnewswire.com/news-releases/amgen-to-terminate-participation-in-co-development-and-commercialization-of-brodalumab-300088098.html (last accessed 29 September 2016).
12. Pitrou I, Boutron I, Ahmad N, Ravaud P. Reporting of safety results in published reports of randomized controlled trials. Arch Intern Med 2009; 169:1756–61.
13. European Medicines Agency. European Medicines Agency policy on publication of clinical data for medicinal products for human use. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2014/10/WC500174796.pdf (last accessed 29 September 2016).
14. Hirsch LJ. Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals. Mayo Clin Proc 2009; 84:811–21.
15. Sigurgeirsson B, Boznanski A, Todd G et al. Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial. Pediatrics 2015; 135:597–606.
16. Ring J, Barker J, Behrendt H et al. Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology Forum. J Eur Acad Dermatol Venereol 2005; 19:663–71.
17. Alvarez F, Meyer N, Gourraud PA, Paul C. CONSORT adoption and quality of reporting of randomized controlled trials: a systematic analysis in two dermatology journals. Br J Dermatol 2009; 161:1159–65.